Armata Pharmaceuticals Inc. Logo

Armata Pharmaceuticals Inc. (ARMP)

NYSE

Currency in USD
5.10
0.00 (0.00%)

Closed

Aug 24, 2026

Day's Range

4.87
5.27

52 wk Range

2.40
16.34

Profile - ARMP - Armata Pharmaceuticals Inc.

Profile

Mic Code

XASE

Sector

Healthcare

Industry

Biotechnology

Employees

60


Armata Pharmaceuticals Inc. is a biotechnology company dedicated to the development of innovative therapies to treat antibiotic-resistant infections. Operating in the healthcare sector, the company focuses on bacteriophage-based solutions, aiming to address the growing global issue of antimicrobial resistance. Armata Pharmaceuticals specializes in researching and developing treatments derived from natural phages, viruses that specifically target and eliminate bacteria, offering an alternative to traditional antibiotics. The company’s efforts are crucial in fields impacted by resistant bacterial strains, including healthcare-associated infections and chronic illnesses linked to bacterial biofilms. With its headquarters in the United States, Armata engages in collaborations with various research institutions and industry partners, emphasizing a scientific approach alongside cutting-edge technology. Armata Pharmaceuticals holds a significant position in the biopharmaceutical market, contributing to the advancement of precision medicine and public health innovations. Its dedication to addressing unmet medical needs positions it as a key player in the development of next-generation antimicrobial therapies. By exploring bacteriophage technology, Armata aims to provide targeted, effective alternatives that could revolutionize how infections are managed globally.

Profile Details

Type

Common Stock

Ceo

Dr. Deborah L. Birx M.D.

Address

5005 McConnell Avenue

City

Los Angeles

State

CA

Zip

90066

Country

United States

Phone

310 665 2928

Key Executives - ARMP - Armata Pharmaceuticals Inc.

Key executives

NamePositionAgePay
Dr. Deborah L. Birx M.D.CEO & Director68851.90K
Mr. Peter HubbardVice President of Operations--
Ms. Bani Tchekanova Ph.D.Head of Regulatory Strategy & Operations--
Dr. Pierre Kyme Ph.D.Chief Business Officer47625.75K

Cross Listings - ARMP - Armata Pharmaceuticals Inc.

Also listed on

The same company trading on other exchanges.

The information on this page is provided for general informational purposes only and is not investment advice.

Market data provided by Twelve Data. Charting by TradingView.

Last updated:

Stocks news

Track Global Markets in Real Time with UA Finance

Download the app now and access live financial data, expert analysis, and trusted economic news to follow stocks, forex, gold, and cryptocurrencies with ease.